positive. Look forward to seeing the trial design. Any ideas when this would start and the funding stream? For the right performance status patients, folfirinox is the preferred regimen everywhere, not just US. Wonder if they’ll run this trial outside US too.
Ann: Type D Meeting Outcome With US Food And Drug Administration, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.005(2.78%) |
Mkt cap ! $67.89M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 21.0¢ | 17.0¢ | $2.549M | 13.34M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 73164 | 4 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| ATX (ASX) Chart |